VIDEO: State Laws and Biosimilar Substitution
by Ha Kung Wong
December 4, 2017
Ha Kung Wong, Molly Burich, Amanda Forys, and Angus Worthing discuss reactions surrounding the enactment of state laws concerning the eventual substitution of interchangable biosimilars for reference products as part of The Center for Biosimilars™ Peer Exchange®.
Ha Kung Wong
has extensive experience litigating a wide variety of pharmaceutical cases, including those concerning biologics used to treat rheumatoid arthritis and autoimmune disorders. He also has extensive experience consulting, conducting due diligence and licensing pharmaceutical portfolios. Ha Kung has a B.S. in Biochemistry and a B.S. in Chemistry.